Cite
Heidsma CM, van Roessel S, van Dieren S, et al. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2021;doi: 10.1159/000518757.
Heidsma, C. M., van Roessel, S., van Dieren, S., Engelsman, A. F., Strobel, O., Buechler, M. W., Schimmack, S., Perinel, J., Adham, M., Deshpande, V., Kjaer, J., Norlen, O., Gill, A. J., Samra, J. S., Mittal, A., Hoogwater, F. J. H., Primavesi, F., Stättner, S., Besselink, M. G., van Eijck, C. H. J., & Nieveen van Dijkum, E. J. M. (2021). International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors. Neuroendocrinology, . https://doi.org/10.1159/000518757
Heidsma, Charlotte M, et al. "International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors." Neuroendocrinology vol. (2021). doi: https://doi.org/10.1159/000518757
Heidsma CM, van Roessel S, van Dieren S, Engelsman AF, Strobel O, Buechler MW, Schimmack S, Perinel J, Adham M, Deshpande V, Kjaer J, Norlen O, Gill AJ, Samra JS, Mittal A, Hoogwater FJH, Primavesi F, Stättner S, Besselink MG, van Eijck CHJ, Nieveen van Dijkum EJM. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2021 Jul 29; doi: 10.1159/000518757. Epub 2021 Jul 29. PMID: 34343138.
Copy
Download .nbib